First Trust Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

First Trust Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-375,813	Closed	-$43.2M	–	2370
2014 Q4	$43.2M	Sell	375,813 -89,516	-19%	-$10.8M	0.15%	164
2014 Q3	$72.7M	Sell	465,329 -25,409	-5%	-$3.68M	0.29%	59
2014 Q2	$60.5M	Sell	490,738 -26,661	-5%	-$2.95M	0.25%	61
2014 Q1	$53.6M	Buy	517,399 +219,628	+74%	+$22.5M	0.24%	68
2013 Q4	$26.8M	Buy	297,771 +4,676	+2%	+$373K	0.13%	176
2013 Q3	$19.6M	Buy	293,095 +34,293	+13%	+$2.36M	0.11%	250
2013 Q2	$17.1M	Buy	+258,802	New	+$14.8M	0.11%	248

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors's SLXP Position: Q1 2015 in Review

First Trust Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 375,813 shares — an estimated $43.2M sold.

First Trust Advisors first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $72.7M in Q3 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

First Trust Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
First Trust Advisors sold 375,813 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $43.2M.
First Trust Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
First Trust Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $72.7M in Q3 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on First Trust Advisors's 13F filing for Q1 2015, filed 4 May 2015.